Literature DB >> 34037804

Inadequate community knowledge about sickle cell disease among the Indian tribal population: a formative assessment in a multicentric intervention study.

Bontha V Babu1, Parikipandla Sridevi2, Shaily Surti3, Manoranjan Ranjit4, Deepa Bhat5, Jatin Sarmah6, Godi Sudhakar7, Yogita Sharma1.   

Abstract

BACKGROUND: Sickle cell disease (SCD) is a serious public health problem, with >300 000 affected births worldwide each year. About 73% of the SCD-affected people in India belong to the tribal population. The Government of India is planning to implement a programme for SCD and hence people's knowledge of SCD is crucial. This paper reports the SCD-related knowledge among the Indian tribal population.
METHODS: As part of a formative assessment before an intervention, data were collected from 9837 adults from 24 primary health centre areas of six states. Each community's knowledge of SCD was elicited through an interviewer-administered pretested questionnaire. Univariate and multivariate analyses were conducted.
RESULTS: Overall, 32.1% (CI 31.2 to 33.1%) of participants had heard of SCD, 7.9% (CI: 7.3 to 8.4%) knew that SCD is hereditary, 19.4% (CI: 18.7 to 20.3%) knew that a blood test can diagnose SCD and 23.9% (CI: 23.1 to 24.8%) knew that SCD is treatable. Only 13.1% (CI: 12.4 to 13.8%) knew that SCD can be prevented. No more than 16% knew about any SCD symptoms. Multiple logistic regression revealed some predictors of basic knowledge (i.e. had heard of SCD).
CONCLUSIONS: There is a gross inadequacy of knowledge about SCD in the Indian tribal population. This study warrants implementing a health education programme as a part of the SCD programme.
© The Author(s) 2021. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Entities:  

Keywords:  beliefs; health education; indigenous communities; knowledge; sickle cell disease; tribal

Mesh:

Year:  2021        PMID: 34037804     DOI: 10.1093/trstmh/trab075

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  1 in total

1.  Anti-factor H antibody associated hemolytic uremic syndrome following SARS-CoV-2 infection.

Authors:  Priyanka Khandelwal; Sudarsan Krishnasamy; Srinivasavaradan Govindarajan; Manish Kumar; Binata Marik; Aditi Sinha; Pankaj Hari; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2022-01-28       Impact factor: 3.651

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.